Logo image of CALX

CALIX INC (CALX) Stock Fundamental Analysis

NYSE:CALX - New York Stock Exchange, Inc. - US13100M5094 - Common Stock - Currency: USD

46.84  +0.66 (+1.43%)

After market: 46.84 0 (0%)

Fundamental Rating

5

CALX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 49 industry peers in the Communications Equipment industry. While CALX has a great health rating, there are worries on its profitability. While showing a medium growth rate, CALX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year CALX was profitable.
CALX had a positive operating cash flow in the past year.
Of the past 5 years CALX 4 years were profitable.
In the past 5 years CALX always reported a positive cash flow from operatings.
CALX Yearly Net Income VS EBIT VS OCF VS FCFCALX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

CALX has a Return On Assets (-3.78%) which is comparable to the rest of the industry.
CALX has a Return On Equity of -4.51%. This is comparable to the rest of the industry: CALX outperforms 55.10% of its industry peers.
Industry RankSector Rank
ROA -3.78%
ROE -4.51%
ROIC N/A
ROA(3y)1.53%
ROA(5y)8.91%
ROE(3y)2.1%
ROE(5y)12.04%
ROIC(3y)N/A
ROIC(5y)N/A
CALX Yearly ROA, ROE, ROICCALX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

The Gross Margin of CALX (54.97%) is better than 71.43% of its industry peers.
In the last couple of years the Gross Margin of CALX has grown nicely.
The Profit Margin and Operating Margin are not available for CALX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.29%
GM growth 5Y4.26%
CALX Yearly Profit, Operating, Gross MarginsCALX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

8

2. Health

2.1 Basic Checks

CALX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CALX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CALX has been increased compared to 5 years ago.
CALX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CALX Yearly Shares OutstandingCALX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CALX Yearly Total Debt VS Total AssetsCALX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

CALX has an Altman-Z score of 12.85. This indicates that CALX is financially healthy and has little risk of bankruptcy at the moment.
CALX has a better Altman-Z score (12.85) than 93.88% of its industry peers.
There is no outstanding debt for CALX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.85
ROIC/WACCN/A
WACC9.79%
CALX Yearly LT Debt VS Equity VS FCFCALX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 4.58 indicates that CALX has no problem at all paying its short term obligations.
CALX has a better Current ratio (4.58) than 87.76% of its industry peers.
CALX has a Quick Ratio of 3.75. This indicates that CALX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CALX (3.75) is better than 91.84% of its industry peers.
Industry RankSector Rank
Current Ratio 4.58
Quick Ratio 3.75
CALX Yearly Current Assets VS Current LiabilitesCALX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for CALX have decreased strongly by -66.21% in the last year.
CALX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 53.42% yearly.
CALX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.75%.
Measured over the past years, CALX shows a quite strong growth in Revenue. The Revenue has been growing by 14.40% on average per year.
EPS 1Y (TTM)-66.21%
EPS 3Y-28.24%
EPS 5Y53.42%
EPS Q2Q%-9.52%
Revenue 1Y (TTM)-18.75%
Revenue growth 3Y6.97%
Revenue growth 5Y14.4%
Sales Q2Q%-2.68%

3.2 Future

The Earnings Per Share is expected to grow by 66.77% on average over the next years. This is a very strong growth
CALX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.37% yearly.
EPS Next Y75%
EPS Next 2Y66.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.76%
Revenue Next 2Y9.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CALX Yearly Revenue VS EstimatesCALX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
CALX Yearly EPS VS EstimatesCALX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 -1 1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 95.59, the valuation of CALX can be described as expensive.
CALX's Price/Earnings ratio is in line with the industry average.
CALX is valuated expensively when we compare the Price/Earnings ratio to 26.60, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 33.02, the valuation of CALX can be described as expensive.
CALX's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CALX to the average of the S&P500 Index (22.43), we can say CALX is valued slightly more expensively.
Industry RankSector Rank
PE 95.59
Fwd PE 33.02
CALX Price Earnings VS Forward Price EarningsCALX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

CALX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 58.09
EV/EBITDA N/A
CALX Per share dataCALX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CALX's earnings are expected to grow with 66.77% in the coming years.
PEG (NY)1.27
PEG (5Y)1.79
EPS Next 2Y66.77%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CALX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALIX INC

NYSE:CALX (5/20/2025, 8:04:00 PM)

After market: 46.84 0 (0%)

46.84

+0.66 (+1.43%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)04-21 2025-04-21/amc
Earnings (Next)07-21 2025-07-21/amc
Inst Owners88.89%
Inst Owner Change1.88%
Ins Owners10.14%
Ins Owner Change0.53%
Market Cap3.04B
Analysts80
Price Target52.02 (11.06%)
Short Float %3.8%
Short Ratio2.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.35%
Min EPS beat(2)7.65%
Max EPS beat(2)47.06%
EPS beat(4)4
Avg EPS beat(4)33.33%
Min EPS beat(4)7.65%
Max EPS beat(4)47.06%
EPS beat(8)7
Avg EPS beat(8)22.24%
EPS beat(12)11
Avg EPS beat(12)23.35%
EPS beat(16)15
Avg EPS beat(16)22.23%
Revenue beat(2)1
Avg Revenue beat(2)1.71%
Min Revenue beat(2)-0.9%
Max Revenue beat(2)4.32%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)4.32%
Revenue beat(8)1
Avg Revenue beat(8)-1.37%
Revenue beat(12)3
Avg Revenue beat(12)-0.26%
Revenue beat(16)6
Avg Revenue beat(16)0.11%
PT rev (1m)1.59%
PT rev (3m)13.75%
EPS NQ rev (1m)35.48%
EPS NQ rev (3m)33.76%
EPS NY rev (1m)25.3%
EPS NY rev (3m)23.94%
Revenue NQ rev (1m)6.3%
Revenue NQ rev (3m)6.02%
Revenue NY rev (1m)4.94%
Revenue NY rev (3m)4.72%
Valuation
Industry RankSector Rank
PE 95.59
Fwd PE 33.02
P/S 3.68
P/FCF 58.09
P/OCF 42.81
P/B 3.96
P/tB 4.66
EV/EBITDA N/A
EPS(TTM)0.49
EY1.05%
EPS(NY)1.42
Fwd EY3.03%
FCF(TTM)0.81
FCFY1.72%
OCF(TTM)1.09
OCFY2.34%
SpS12.73
BVpS11.84
TBVpS10.04
PEG (NY)1.27
PEG (5Y)1.79
Profitability
Industry RankSector Rank
ROA -3.78%
ROE -4.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.97%
FCFM 6.33%
ROA(3y)1.53%
ROA(5y)8.91%
ROE(3y)2.1%
ROE(5y)12.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.29%
GM growth 5Y4.26%
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 98.42%
Cap/Sales 2.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.58
Quick Ratio 3.75
Altman-Z 12.85
F-Score6
WACC9.79%
ROIC/WACCN/A
Cap/Depr(3y)99.33%
Cap/Depr(5y)84.93%
Cap/Sales(3y)1.84%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.21%
EPS 3Y-28.24%
EPS 5Y53.42%
EPS Q2Q%-9.52%
EPS Next Y75%
EPS Next 2Y66.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.75%
Revenue growth 3Y6.97%
Revenue growth 5Y14.4%
Sales Q2Q%-2.68%
Revenue Next Year8.76%
Revenue Next 2Y9.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-445.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year124.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y318.93%
FCF growth 3Y2.81%
FCF growth 5YN/A
OCF growth 1Y153.92%
OCF growth 3Y6.39%
OCF growth 5Y71.21%